Mirhakkak, Mohammad H
Schäuble, Sascha http://orcid.org/0000-0003-3862-6546
Klassert, Tilman E
Brunke, Sascha
Brandt, Philipp
Loos, Daniel http://orcid.org/0000-0002-4024-4443
Uribe, Ruben V
Senne de Oliveira Lino, Felipe
Ni, Yueqiong
Vylkova, Slavena
Slevogt, Hortense
Hube, Bernhard
Weiss, Glen J
Sommer, Morten O A http://orcid.org/0000-0003-4005-5674
Panagiotou, Gianni http://orcid.org/0000-0001-9393-124X
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (210879364)
Novo Nordisk Fonden (NNF10CC1016517, NNF17CO0028232)
Bundesministerium für Bildung und Forschung (03Z22JN11)
Deutsche Forschungsgemeinschaft (210879364, 210879364, 210879364)
Novo Nordisk Fonden (NNF10CC1016517, NNF17CO0028232, NNF10CC1016517, NNF17CO0028232)
Bundesministerium für Bildung und Forschung (03Z22JN11)
Article History
Received: 15 April 2020
Revised: 6 November 2020
Accepted: 18 November 2020
First Online: 15 December 2020
Compliance with ethical standards
:
: GJW is an employee of SOTIO and former employee of Unum Therapeutics, reports personal fees from MiRanostics Consulting, Paradigm, Genomic Health, Angiex, Imaging Endpoints II, IBEX Medical Analytics, Spring Bank Pharmaceuticals, Pfizer, IDEA Pharma, GLG Council, Guidepoint Global, Ignyta, and Circulogene; has received travel reimbursement from Cambridge HealthTech Institute, GlaxoSmith Kline, and Tesaro; has ownership interest in MiRanostics Consulting, Exact Sciences, and Circulogene; and has a patent for methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer issued. All other authors declare no competing interests.